This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

31 Aug 2017


Dextrose (glucose monohydrate) injectable

  • Unique Offer
  • Highest Quality Standards
  • Guaranteed Traceability
  • Expertise at your Service
  • Reliable Partner

One of the first sugar groups to have adopted a dedicated approach to the pharmaceutical industry. Leading producer of sugar, starch, starch derivatives and alcohol in Europe, Tereos processes plant-based and renewable raw materials, using the best available technologies and following Good Manufacturing Practices. Tereos ensures high purity and controlled composition of its products, which comply with the regulatory requirements of the pharmaceutical industry. Tereos’s portfolio offers an extensive range of sucrose and starch based pharmaceutical excipients and actives for use in oral drug delivery, clinical nutrition, dialysis and injectable solutions.

Tereos : World’s 2nd largest sugar group. The long-term vision of Tereos is to fully exploit the value of agricultural raw materials and develop quality products. Tereos is a leader in the sugar, alcohol and starch markets. The Group’s commitments to society and the environment contribute to the company’s performance in the long term while strengthening its contribution as a responsible player. The cooperative group Tereos is a union of 12,000 farmers and has recognized know-how in the processing of beet, sugarcane and cereals. Through 49 industrial sites in 17 countries and the commitment of its 25.000 employees, Tereos supports its customers close to their markets with a broad and complementary range of products. In 2017/18, the group achieved a turnover of €5 billion.

Mentioned Companies
View company profile